T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study.

Saved in:
Bibliographic Details
Title: T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study.
Authors: Gainor JF; Massachusetts General Hospital, Boston, Massachusetts., Patel MR; Florida Cancer Specialists, Sarasota, Florida.; Sarah Cannon Research Institute, Nashville, Tennessee., Weber JS; Perlmutter Cancer Center at NYU Langone Health, New York, New York., Gutierrez M; Hackensack University Medical Center, Hackensack, New Jersey., Bauman JE; George Washington University Cancer Center, Washington, District of Columbia., Clarke JM; Duke University Medical Center, Durham, North Carolina., Julian R; University of Arizona Cancer Center, Tucson, Arizona., Scott AJ; University of Arizona Cancer Center, Tucson, Arizona., Geiger JL; The Cleveland Clinic Foundation, Cleveland, Ohio., Kirtane K; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Robert-Tissot C; Moderna, Inc., Cambridge, Massachusetts., Coder B; Moderna, Inc., Cambridge, Massachusetts., Tasneem M; Moderna, Inc., Cambridge, Massachusetts., Sun J; Moderna, Inc., Cambridge, Massachusetts., Zheng W; Moderna, Inc., Cambridge, Massachusetts., Gerbereux L; Moderna, Inc., Cambridge, Massachusetts., Laino A; Moderna, Inc., Cambridge, Massachusetts., Porichis F; Moderna, Inc., Cambridge, Massachusetts., Pollard JR; Moderna, Inc., Cambridge, Massachusetts., Hou P; Moderna, Inc., Cambridge, Massachusetts., Sehgal V; Moderna, Inc., Cambridge, Massachusetts., Chen X; Moderna, Inc., Cambridge, Massachusetts., Morrissey M; Moderna, Inc., Cambridge, Massachusetts., Daghestani HN; Moderna, Inc., Cambridge, Massachusetts., Feldman I; Moderna, Inc., Cambridge, Massachusetts., Srinivasan L; Moderna, Inc., Cambridge, Massachusetts., Frederick JP; Moderna, Inc., Cambridge, Massachusetts., Brown M; Moderna, Inc., Cambridge, Massachusetts., Aanur P; Moderna, Inc., Cambridge, Massachusetts., Meehan R; Moderna, Inc., Cambridge, Massachusetts., Burris HA 3rd; Sarah Cannon Research Institute, Nashville, Tennessee.
Source: Cancer discovery [Cancer Discov] 2024 Nov 01; Vol. 14 (11), pp. 2209-2223.
Publication Type: Journal Article; Clinical Trial, Phase I
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2159-8290
DOI:10.1158/2159-8290.CD-24-0158